Megan Boston - Net Worth and Insider Trading
Megan Boston Net Worth
The estimated net worth of Megan Boston is at least $252,270 dollars as of 2024-11-29. Megan Boston is the Executive Director of Benitec Biopharma Inc and owns about 25,927 shares of Benitec Biopharma Inc (BNTC) stock worth over $252,270. Details can be seen in Megan Boston's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Megan Boston has not made any transactions after 2023-08-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Megan Boston
Megan Boston Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Megan Boston owns 1 companies in total, including Benitec Biopharma Inc (BNTC) .
Click here to see the complete history of Megan Boston’s form 4 insider trades.
Insider Ownership Summary of Megan Boston
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BNTC | Benitec Biopharma Inc | 2023-08-11 | director & Executive Director |
Megan Boston Latest Holdings Summary
Megan Boston currently owns a total of 1 stock. Megan Boston owns 25,927 shares of Benitec Biopharma Inc (BNTC) as of August 11, 2023, with a value of $252,270.
Latest Holdings of Megan Boston
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BNTC | Benitec Biopharma Inc | 2023-08-11 | 25,927 | 9.73 | 252,270 |
Holding Weightings of Megan Boston
Megan Boston Form 4 Trading Tracker
According to the SEC Form 4 filings, Megan Boston has made a total of 1 transactions in Benitec Biopharma Inc (BNTC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Benitec Biopharma Inc is the acquisition of 25,907 shares on August 11, 2023, which cost Megan Boston around $72,799.
Insider Trading History of Megan Boston
- 1
Megan Boston Trading Performance
GuruFocus tracks the stock performance after each of Megan Boston's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Megan Boston is 21.71%. GuruFocus also compares Megan Boston's trading performance to market benchmark return within the same time period. The performance of stocks bought by Megan Boston within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Megan Boston's insider trading performs compared to the benchmark.
Performance of Megan Boston
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.52 | | | | | |
| Relative Return to S&P 500(%) | 13 | | | | | |
Megan Boston Ownership Network
Megan Boston Owned Company Details
What does Benitec Biopharma Inc do?
Who are the key executives at Benitec Biopharma Inc?
Megan Boston is the director & Executive Director of Benitec Biopharma Inc. Other key executives at Benitec Biopharma Inc include 10 percent owner Steven Michael Oliveira , 10 percent owner Patrick Soon-shiong , and 10 percent owner California Capital Equity, Llc .
Benitec Biopharma Inc (BNTC) Insider Trades Summary
Over the past 18 months, Megan Boston made 1 insider transaction in Benitec Biopharma Inc (BNTC) with a net purchase of 25,907. Other recent insider transactions involving Benitec Biopharma Inc (BNTC) include a net purchase of 51,813 shares made by J Kevin Buchi , a net purchase of 41,436 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Benitec Biopharma Inc (BNTC) in total and bought 41,436 shares, with a net purchase of 41,436 shares. During the past 18 months, 0 shares of Benitec Biopharma Inc (BNTC) were sold and 119,156 shares were bought by its insiders, resulting in a net purchase of 119,156 shares.
Benitec Biopharma Inc (BNTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Benitec Biopharma Inc Insider Transactions
Megan Boston Mailing Address
Above is the net worth, insider trading, and ownership report for Megan Boston. You might contact Megan Boston via mailing address: Level 14, 114 William St, Melbourne, Vic C3 3000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
